Cidara Therapeutics, Inc. (CDTX) is a publicly traded Healthcare sector company. As of May 20, 2026, CDTX trades at $221.38 with a market cap of $6.96B and a P/E ratio of -8.28. CDTX moved +0.03% today. Year to date, CDTX is +228.02%; over the trailing twelve months it is +731.63%. Its 52-week range spans $10.14 to $221.42. Analyst consensus is buy with an average price target of $221.50. Rallies surfaces CDTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading CDTX stock inside the company?
Recent CDTX insider activity includes Ward Shane sold 9.96K, Davarpanah Nicole Negar sold 474, RA CAPITAL MANAGEMENT, L.P. bought 2.27M, Mineo Chrysa bought 1.05K, and Mineo Chrysa bought 2.27K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
CDTX Key Metrics
Key financial metrics for CDTX
Metric
Value
Price
$221.38
Market Cap
$6.96B
P/E Ratio
-8.28
EPS
$-26.75
Dividend Yield
0.00%
52-Week High
$221.42
52-Week Low
$10.14
Volume
2.69M
Avg Volume
0
Revenue (TTM)
$1.27M
Net Income
$-169.83M
Gross Margin
0.00%
Recent CDTX Insider Trades
Ward Shane sold 9.96K (~$2.19M) on Dec 10, 2025.
Davarpanah Nicole Negar sold 474 (~$29.80K) on Sep 11, 2025.
RA CAPITAL MANAGEMENT, L.P. bought 2.27M (~$100.00M) on Jun 26, 2025.
Mineo Chrysa bought 1.05K (~$24.61K) on Jun 3, 2025.
Mineo Chrysa bought 2.27K (~$49.28K) on Jun 2, 2025.
Recent CDTX insider activity includes Ward Shane sold 9.96K, Davarpanah Nicole Negar sold 474, RA CAPITAL MANAGEMENT, L.P. bought 2.27M, Mineo Chrysa bought 1.05K, and Mineo Chrysa bought 2.27K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CDTX?
Yes. Rallies tracks CDTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CDTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CDTX. It does not provide personalized investment advice.